Related Experiment Videos
Idiopathic reactive hypoglycemia: a role for glucagon?
F Leonetti1, L Morviducci, A Giaccari
1Cattedra di Endocrinologia, Università di Roma La Sapienza, Italy.
Journal of Endocrinological Investigation
|April 1, 1992
Summary
Patients with idiopathic reactive hypoglycemia have increased insulin sensitivity. Glucagon replacement normalized this sensitivity, suggesting glucagon plays a key role in the pathogenesis of hypoglycemia in these patients.
Area of Science:
- Endocrinology
- Metabolic Disorders
Background:
- Idiopathic reactive hypoglycemia is characterized by low plasma glucose concentrations after a meal.
- Patients exhibit reduced glucagon secretion and heightened insulin sensitivity.
- The precise role of glucagon in this increased insulin sensitivity remains unclear.
Purpose of the Study:
- To investigate the effect of glucagon on the increased insulin sensitivity observed in patients with idiopathic reactive hypoglycemia.
Main Methods:
- A two-step hyperinsulinemic euglycemic glucose clamp was performed on 12 patients with idiopathic reactive hypoglycemia and 12 matched controls.
- The clamp involved insulin and glucose infusion, with and without glucagon replacement.
Main Results:
- During the initial clamp phase (without glucagon), patients required higher glucose infusion rates, indicating greater insulin sensitivity.
- Upon replacement of basal glucagon secretion in the second phase, glucose infusion rates decreased significantly in patients, becoming similar to control subjects.
- This suggests glucagon plays a crucial role in modulating insulin sensitivity.
Conclusions:
- Glucagon secretion significantly influences insulin sensitivity in patients with idiopathic reactive hypoglycemia.
- Reduced glucagon levels may contribute to the exaggerated insulin sensitivity and subsequent hypoglycemia observed in these individuals.